Stay updated on Combination Immunotherapy in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immunotherapy in Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 CheckMate 9KD study of nivolumab combinations for metastatic castration-resistant prostate cancer, including study design, participant criteria, locations, and reported outcomes.
    Difference
    96%
    Check dated 2026-11-08T15:08:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T16:14:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:36:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the study record page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T21:57:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T21:57:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the HTML skeleton (doctype, meta, and a 403 title) and a Home link. This reflects an access restriction rather than substantive updates to the trial information on the page.
    Difference
    20%
    Check dated 2026-09-20T20:32:23.000Z thumbnail image

Stay in the know with updates to Combination Immunotherapy in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.